Delivery Order SPE2DR25D1104-SPE2DR26FK242
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $112,075.84 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This firm fixed-price contract, which was competitively awarded without a set-aside designation, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,906.45 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on May 30, 2025, with completion expected by June 2, 2025. This firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.9 billion global...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens valued at $4,370.58 on July 29, 2025, with ultimate completion scheduled for July 30, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a $5,268.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 mL pens on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside competitive award is being fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $93,571.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen injectors on September 9, 2025, with completion targeted for September 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion prime vendor agreement designated SPE2DX and extending through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.74 to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Zepbound 5 mg/0.5 mL pens with a ceiling value of $6,208.02. This firm fixed-price delivery order is a non-set-aside award and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the contractor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,426.06 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pens on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,273.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with an ultimate completion date of August 18, 2025. This is a non-set-aside competitive award leveraging AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that runs through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens on August 15, 2025, with a ceiling value of $8,246.40 and an ultimate completion date of August 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK242Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pens valued at $10,335.92 on November 5, 2025, with completion scheduled for November 6, 2025. This firm fixed-price delivery order represents a non-competitive award under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors and a critical supplier to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. This delivery order is issued under AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The contract provides comprehensive global pharmaceutical support, enabling the company to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The award of Zepbound, a diabetes medication, demonstrates the contractor's role in supplying specialty pharmaceuticals to federal military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 11/5/25 |